Hrt Financial LP Global Blood Therapeutics, Inc. Transaction History

Hrt Financial LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	BUY	$32.4 - $68.18 $6.91 Million - $14.5 Million	213,168 New	213,168 $14.5 Million
Q4 2021 Feb 14, 2022	SELL	$24.9 - $40.26 $1.14 Million - $1.84 Million	-45,632 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$25.48 - $37.34 $1.16 Million - $1.7 Million	45,632 New	45,632 $1.16 Million
Q3 2020 Nov 13, 2020	SELL	$52.76 - $74.49 $2.34 Million - $3.31 Million	-44,442 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$48.73 - $81.82 $2.17 Million - $3.64 Million	44,442 New	44,442 $2.81 Million
Q4 2019 Feb 14, 2020	SELL	$45.7 - $81.86 $251,807 - $451,048	-5,510 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$45.35 - $57.91 $249,878 - $319,084	5,510 New	5,510 $267,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Hrt Financial LP, based on Form 13F filings with the SEC.

Stay updated on Hrt Financial LP with notifications on news.